CXCL8 and neoplasm: Therefore, the LoD achieved in this work makes the platform particularly suitable for continuous monitoring of IL-8 in models reproducing moderate-to-high cytokine expression levels, such as tumor-on-a-chip systems or therapeutic response assays.